Tjalf Ziemssen Selected Research

Tjalf Ziemssen Research Topics

Disease

97	Multiple Sclerosis 11/2022 - 11/2002
41	Relapsing-Remitting Multiple Sclerosis 04/2022 - 09/2008
6	Progressive Multifocal Leukoencephalopathy 02/2022 - 04/2011
6	Disease Progression 01/2021 - 06/2016
6	Infections 01/2021 - 04/2011
5	Inflammation (Inflammations) 11/2021 - 12/2009
5	Fatigue 01/2017 - 09/2008
4	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 04/2011
4	Stroke (Strokes) 10/2021 - 02/2007
4	Chronic Progressive Multiple Sclerosis 10/2020 - 01/2017
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 12/2011
3	Optic Neuritis (Retrobulbar Neuritis) 12/2018 - 03/2017
3	Hypercholesterolemia 01/2013 - 12/2009
2	Hepatolenticular Degeneration (Wilson's Disease) 01/2022 - 01/2017
2	Neuroacanthocytosis 05/2021 - 01/2021
2	Nervous System Diseases (Neurological Disorders) 04/2021 - 05/2015
2	Seizures (Absence Seizure) 02/2021 - 07/2011
2	Weight Gain 01/2021 - 10/2018
2	Pain (Aches) 01/2021 - 12/2015
2	Bradycardia 01/2020 - 01/2017
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 01/2019
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2019 - 08/2007
2	Pulmonary Arterial Hypertension 07/2019 - 06/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 09/2017
2	Obesity 01/2017 - 12/2009
2	Orthostatic Hypotension (Postural Hypotension) 01/2017 - 02/2010
2	Demyelinating Diseases (Demyelinating Disease) 01/2016 - 11/2005
2	Hyperlipidemias (Hyperlipidemia) 05/2015 - 05/2015
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2015 - 06/2014
2	Hyperhomocysteinemia 05/2015 - 05/2015
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2009 - 01/2004
1	COVID-19 11/2022
1	Hypoxia (Hypoxemia) 10/2022
1	Drug-Related Side Effects and Adverse Reactions 06/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Nervous System Trauma 01/2022
1	Ulcerative Colitis 01/2022
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 10/2021
1	Sarcoma (Soft Tissue Sarcoma) 07/2021
1	Rare Diseases (Rare Disease) 05/2021
1	Injection Site Reaction 01/2021

Drug/Important Bio-Agent (IBA)

24	Fingolimod Hydrochloride (FTY720)FDA Link 06/2022 - 12/2013
18	Alemtuzumab (Campath)FDA Link 01/2022 - 01/2015
16	Glatiramer Acetate (Copaxone)FDA Link 01/2022 - 11/2002
15	Natalizumab (Tysabri)FDA Link 02/2022 - 09/2010
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
8	Retinaldehyde (Retinal)IBA 01/2021 - 08/2009
7	Pharmaceutical PreparationsIBA 01/2022 - 02/2010
6	Monoclonal AntibodiesIBA 11/2021 - 04/2011
4	Interferon beta-1a FDA Link 01/2022 - 01/2017
3	Cladribine FDA LinkGeneric 11/2022 - 11/2020
3	laquinimodIBA 04/2022 - 06/2016
3	Sphingosine-1-Phosphate ReceptorsIBA 01/2022 - 01/2018
3	Dimethyl FumarateIBA 01/2022 - 01/2020
3	Immunoglobulin G (IgG)IBA 01/2022 - 08/2007
3	Complement System Proteins (Complement)IBA 10/2021 - 01/2018
3	FumaratesIBA 01/2021 - 01/2020
3	diroximel fumarateIBA 01/2021 - 01/2020
3	siponimodIBA 07/2020 - 08/2013
3	AutoantibodiesIBA 01/2020 - 08/2007
3	Interferon-betaIBA 07/2019 - 09/2015
3	opicinumabIBA 12/2018 - 03/2017
3	Vasodilator Agents (Vasodilators)IBA 09/2015 - 02/2010
2	TabletsIBA 11/2022 - 01/2020
2	IntegrinsIBA 11/2021 - 01/2017
2	Phosphotransferases (Kinase)IBA 05/2021 - 01/2021
2	InterferonsIBA 01/2021 - 07/2019
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2021 - 07/2016
2	tau Proteins (tau Protein)IBA 01/2021 - 01/2021
2	AntigensIBA 01/2020 - 02/2007
2	Phosphates (Orthophosphate)IBA 01/2020 - 01/2018
2	CannabidiolIBA 01/2019 - 01/2019
2	Dronabinol (THC)FDA LinkGeneric 01/2019 - 01/2019
2	AntibodiesIBA 05/2015 - 08/2007
2	Methionine (L-Methionine)FDA Link 05/2015 - 05/2015
2	Bevacizumab (Avastin)FDA Link 05/2013 - 08/2009
2	oxidized low density lipoproteinIBA 11/2010 - 12/2009
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2005 - 11/2002
1	NucleosidesIBA 11/2022
1	Phosphopyruvate Hydratase (Enolase)IBA 10/2022
1	N 30IBA 05/2022
1	teriflunomideIBA 01/2022
1	ofatumumab FDA Link 01/2022
1	ozanimodIBA 01/2022
1	2'-deoxyadenosineIBA 11/2021
1	ProdrugsIBA 11/2021
1	Interleukin-17 (Interleukin 17)IBA 07/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021

Therapy/Procedure

53	Therapeutics 02/2022 - 11/2002
4	Blood Component Removal (Apheresis) 12/2019 - 12/2009
2	Injections 01/2022 - 12/2015
2	Drug Therapy (Chemotherapy) 01/2021 - 05/2013
2	Immunotherapy 01/2019 - 01/2017
2	Aftercare (After-Treatment) 01/2018 - 01/2015
2	Activities of Daily Living (ADL) 01/2017 - 12/2011
2	Immunomodulation 06/2014 - 02/2007
2	Magnetic Field Therapy 11/2011 - 05/2009
1	Deep Brain Stimulation 01/2022